Back to results
US 10,441,565 B2Granted
Conjugate of memantine and arctigenin, and composition and use thereof
AssigneeShenzhen Qingyaqirui Bio-Tech Co., Ltd.
InventorsHaifeng Sun, Zhiyuan Zhu, Jun Liu, Wei Yan, Ding Zhang, Jing Yang
Life of this patent
Estimating the term…
Abstract
Provided are a conjugate of memantine and arctigenin, and a pharmaceutical composition comprising the conjugate. The conjugate can treat diseases associated with Aβ or Tau protein pathways, such as Alzheimer's disease or Parkinson's disease.
Claims14
A conjugate comprising a compound of formula (I), or a pharmaceutically acceptable salt, stereoisomer, polymorph, or solvate thereof:
- wherein:
- Linker 1 is selected from the group consisting of —C(O)—, —C(O)L1C(O)—, —C(O)OL1C(O)—, —C(O)OL1OC(O)—, —C(O)OQ1L2Q2-, —C(O)Q1L2Q2N(R1)C(O)—, —C(O)Q1L2Q2OC(O)—, —C(O)Q1L2Q2C(O)—, —C(O)OQ1L2Q2OC(O)—, —C(O)OQ1L1Q2N(R1)C(O)—, —C(O)OQ1L2Q2N(R1)C(O)— and —C(O)OQ1L2Q2C(O)—;
- L1 is a direct bond, or is selected from the group consisting of —O—, —S—, —NR2—, substituted or unsubstituted C1-C6 straight or branched alkylene, substituted or unsubstituted C2-C6 straight or branched alkenylene, substituted or unsubstituted C2-C6 straight or branched alkynylene, substituted or unsubstituted C3-C10 cyclrejectionlkylene, substituted or unsubstituted C3-C10 non-aromatic heterocyclylene, substituted or unsubstituted C6-C14 arylene, substituted or unsubstituted C6-C14 heterrectionrylene, and substituted or unsubstituted C6-C20 aralkylene;
- L2 is a direct bond, or is selected from the group consisting of —NR2—, —O—, —C(O)—, —N(R3)C(O)—, —C(O)N(R3)—, —C(O)O—, —OC(O)—, —N(R3)Q3O—, —N(R3)C(O)Q3O—, —N(R3)C(O)Q3C(O)—, —N(R3)C(O)Q3N(R3)—, —N(R3)C(O)Q3C(O)N(R3)—, —N(R3)C(O)Q3N(R3)C(O)—, —N(R3)C(O)Q3C(O)O—, —N(R3)C(O)Q3OC(O)—, —C(O)N(R3)Q3C(O)N(R3)—, —C(O)N(R3)Q3C(O)O—, —C(O)N(R3)Q3N(R3)C(O)—, —C(O)N(R3)Q3OC(O)—, —N(R3)Q3C(O)N(R3)—, —N(R3)Q3C(O)O—, —N(R3)Q3N(R3)C(O)—, —N(R3)Q3OC(O)—, —OQ3N(R3)—, —OQ3C(O)N(R3)—, —OQ3C(O)O—, —OQ3N(R3)C(O)—, —OQ3OC(O)—, —OC(O)Q3-, —OC(O)Q3C(O)N(R3)—, —OC(O)Q3C(O)O—, —OC(O)Q3N(R3)—, —OC(O)Q3N(R3)C(O)—, —OC(O)Q3N(R3)L1O—, —OC(O)Q3OC(O)—, —C(O)OQ3-, —C(O)OQ3O—, —C(O)OQ3C(O)N(R3)—, —C(O)OQ3C(O)O—, —C(O)OQ3N(R3)C(O)— or —C(O)OQ3OC(O)—;
- Q1, Q2 and Q3 are each independently selected from the group consisting of substituted or unsubstituted C1-C6 straight or branched alkylene, substituted or unsubstituted C3-C10 cyclrejectionlkylene, substituted or unsubstituted C2-C6 straight or branched alkenylene, substituted or unsubstituted C2-C6 straight or branched alkynylene, substituted or unsubstituted C3-C10 non-aromatic heterocyclylene, substituted or unsubstituted C6-C14 arylene, substituted or unsubstituted C6-C14 heterrejectionrylene, and substituted or unsubstituted C6-C20 aralkylene;
- and
- R1, R2 and R3 are each independently selected from the group consisting of H and C1-C6 alkyl.
4 more elements
Dependencies are inferred from the claim text.